Theme: Innovative Approaches of BA/BE to Revolutionize the Next Generation Medicine


Renowned Speakers


OMICS Group International is combination of Open Access publications and worldwide international Scientific Conferences and events. OMICS Publishing Group was established in the year 2007 with the sole aim to produce sciences and technology information and also publishes 350 online Open Access Journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been a source in taking the Knowledge on science and technology to the doorsteps of ordinary men and women. It organizes 100 International conferences every year all over the world. 30000 editorial team are working with OMICS Group and the review process is quick and quality which takes 21days and publishes immediately after acceptance.

OMICS Group cordially invites all the participants across the globe to attend the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA. Bioavailability and bioequivalence World Congress 2014 is a platform for various people from pharmaceutical backgrounds, HealthCare institutions, Pharmaceutical regulatory agencies, Biotech and Clinical Research organizations. The main theme of the World Congress meeting is “Innovative Approaches of BA/BE to Revolutionize the Next Generation Medicine”. We make sure that scientists and researchers get the popularity and rewards that they be and also the chance to play a big role within the international scientific community. This pharmaceutical conference helps for young researchers by giving them a chance to present their work and conjointly offers moment to share and seeking advices from experts from their respective fields. OMICS Group International Conference is a fascinating conference wherever participants will communicate and reciprocally get benefited by sharing experiences regarding their individual fields of interest, build collaborations with research organizations, acquire edges from interactive workshops, promote innovative designs, trends and advancements. BABE-2014 is comprised of 14 tracks and 76 sessions designed to offer comprehensive sessions that address current issues in Bioavailability and Bioequivalence.

Conference Highlights

  • Emerging Bioavailability and Bioequivalence Studies
  • Bioanalytical Methodology
  • Contemporary Challenges of Drug Design, Discovery and Development
  • Regulatory Policies, Procedures and Prerequisites for Clinical Research
  • Managing BA/BE Studies
  • Relevance of Genetics to BA/BE in Drug Development
  • Bioavailability, Bioequivalence and Drug Product Selection
  • Advances in Assessment of Bioequivalence
  • Need for Conducting BA/BE Studies
  • Metabolic Pathways and Changes in Nutrient Bioavailability
  • Clinical Pharmacokinetics
  • Clinical Pharmacology and Therapeutics
  • Translational Cancer Research and Anticancer Drug Discovery.
  • Chronopharmaceutics: Germane Approach to Drug Delivery

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 29-October 01, 2014
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Scientific Program
Poster Opportunity Closed Click Here to View